During obesity, interferon regulator factor 5 (IRF5) regulates the pro-inflammatory polarization of ATM, and deficiency of IRF5 promotes a type 2 immune regulatory environment via ATM-derived transforming growth factor β (TGF-β) (32). Here, ATM is linked to obesity disorder.